Literature DB >> 15856269

The changing motives of cesarean section: from the ancient world to the twenty-first century.

Samuel Lurie1.   

Abstract

BACKGROUND: Cesarean delivery has been practiced for ages, although originally as a universally postmortem procedure. It is referred to in the myths and folklore of many ancient societies, for some of the infants delivered in this way survived, even though their mothers did not. Since the Renaissance, the objective of the procedure has gradually shifted towards saving the lives of both the mother and the child, and this has become ever more possible, as maternal and perinatal mortality and morbidity decreased dramatically during the twentieth century. CURRENT ISSUES: Today (at the beginning of twenty-first century), we are not only concerned with the safety and health of the mother and the child, but also with mother's desires and preferences and the child's rights.

Entities:  

Mesh:

Year:  2005        PMID: 15856269     DOI: 10.1007/s00404-005-0724-4

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  Frequency of placenta previa in previously scarred and non scarred uterus.

Authors:  Tayyaba Majeed; Fatima Waheed; Zahid Mahmood; Kanwal Saba; Hamis Mahmood; Mulazim Hussain Bukhari
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

2.  Postmortem and perimortem cesarean section: historical, religious and ethical considerations.

Authors:  Hossam E Fadel
Journal:  J IMA       Date:  2011-12

3.  A Rare Case of Transvesical Cesarean Section.

Authors:  Sunil Kumar Juneja; Pooja Tandon; Bakul Kochhar; Harman Deep Singh; Bhanupriya Sharma
Journal:  Int J Appl Basic Med Res       Date:  2017 Jul-Sep

4.  Women Aged over 40 with Twin Pregnancies Have a Higher Risk of Adverse Obstetrical Outcomes.

Authors:  María De la Calle; Jose L Bartha; Laura García; Marcos J Cuerva; David Ramiro-Cortijo
Journal:  Int J Environ Res Public Health       Date:  2021-12-12       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.